| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.9M | -5.9% | -22.1% |
| Cost of Revenue | $4.2M | -5.5% | +15.9% |
| Gross Profit | $2.7M | -6.5% | -48.2% |
| R&D Expense | $1.8M | +23.7% | +110.8% |
| SG&A Expense | $1.9M | -3.5% | +21.9% |
| Operating Income | -$2.6M | -32.2% | -271.8% |
| Pre-tax Income | -$2.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $24.5M | +10.3% | +8.4% |
| Accounts Receivable | $9.3M | -26.0% | -45.0% |
| Inventory | $13.0M | +5.1% | +9.0% |
| Current Assets | $50.2M | -3.9% | -8.4% |
| Total Assets | $58.3M | -0.9% | -2.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.7M | — | — |
| Capital Expenditures | $38K | — | — |
| Investing Cash Flow | -$38K | — | — |
| Financing Cash Flow | -$300K | — | — |
| Free Cash Flow | $2.7M | — | — |
| -36.9% |
| -235.8% |
| Income Tax | -$1.5M | -102.8% | -362.3% |
| Net Income | -$943K | +9.1% | -177.6% |
| EPS (Basic) | -$0.06 | +0.0% | -185.7% |
| EPS (Diluted) | -$0.06 | +0.0% | -185.7% |
| $6.8M |
| +6.1% |
| +30.6% |
| Total Liabilities | $7.1M | +4.6% | +24.0% |
| Stockholders' Equity | $51.2M | -1.7% | -5.4% |